Mankind Pharma Q4 Results

  • BSE: 543904
  • NSE: MANKIND
  • ISIN: INE634S01028
  • Sector: -
BSE
2,117.5-30.20 (-1.41%)
Volume7.82 K
Updated: Tue 16 Jul, 2024 | 15:29:40
NSE
2,115.7-32.90 (-1.53%)
Volume3.76 L
Updated: Tue 16 Jul, 2024 | 15:44:08
Today: 2,110.50
2,150.85
52-Wk: 1,680.50
2,488.65

Q4 Results Highlights

  • Total Income
    ₹2,441.10 Cr.
    (18.92%)
  • Operating Profit
    ₹486.42 Cr.
    (46.44%)
  • Profit After Tax
    ₹471.24 Cr.
    (65.09%)
  • Operating Margin
    19.93%
    (23.14%)
Note: Comparison is on YoY basis

Quarterly - Mankind Pharma Q4 Results

*All figures in crores except per share values
Fiscal PeriodMar 24Dec 23QoQ CompMar 23YoY Comp
Total Revenue 2,441.102,606.96-6.36%2,052.6718.92%
Selling/ General/ Admin Expenses Total 581.51568.352.31%495.8817.27%
Depreciation/ Amortization 104.69109.73-4.59%84.5223.86%
Other Operating Expenses Total 531.20604.51-12.13%466.4213.89%
Total Operating Expense 1,954.682,110.18-7.37%1,720.5113.61%
Operating Income 486.42496.78-2.09%332.1646.44%
Net Income Before Taxes 571.58562.331.64%377.2951.50%
Net Income 471.24453.763.85%285.4465.09%
Diluted Normalized EPS 11.7411.313.80%7.1364.69%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts